Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.

Bone marrow transplantation·2016
Same author

Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.

Leukemia & lymphoma·2016

Related Experiment Video

Updated: May 12, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Cataract formation after bone marrow transplantation

A Tichelli1, A Gratwohl, T Egger

  • 1University Hospitals, Basel, Switzerland.

Annals of Internal Medicine
|December 15, 1993
PubMed
Summary
This summary is machine-generated.

Bone marrow transplant recipients, especially those receiving single-dose total-body irradiation (TBI), have a high incidence of cataracts. Long-term steroid use also accelerates cataract formation, necessitating preventive measures.

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Related Experiment Videos

Last Updated: May 12, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Area of Science:

  • Hematology
  • Oncology
  • Ophthalmology

Background:

  • Bone marrow transplantation (BMT) is a critical treatment for various hematologic malignancies and other diseases.
  • Cataract formation is a known complication following BMT, particularly with radiation-based conditioning regimens.
  • Understanding the incidence and risk factors for post-BMT cataracts is crucial for long-term patient care.

Purpose of the Study:

  • To investigate the incidence, temporal progression, and associated risk factors of cataract development in patients undergoing bone marrow transplantation.
  • To compare cataract rates between different conditioning regimens, including single-dose total-body irradiation (TBI), fractionated TBI, and chemotherapy alone.
  • To identify factors influencing the need for cataract surgery post-BMT.

Main Methods:

  • A prospective cohort study was conducted with 197 patients receiving allogeneic or autologous BMT.
  • Patients were stratified based on conditioning regimens: single-dose TBI (n=74), fractionated TBI (n=90), and chemotherapy alone (n=33).
  • Data on cataract development, time course, and potential risk factors (irradiation dose, steroid use, age, sex, graft-versus-host disease) were collected and analyzed using Cox regression.

Main Results:

  • High incidence of cataracts observed: 69% in single-dose TBI, 20% in fractionated TBI, and 3% in chemotherapy-alone groups.
  • Single-dose TBI led to earlier and more frequent cataract development compared to fractionated TBI (P < 0.01).
  • Significant risk factors for cataracts included irradiation (RR 21.0), mode of irradiation (RR 7.4), and prolonged steroid use (>3 months, RR 2.9).

Conclusions:

  • Patients receiving TBI for BMT face a high likelihood of developing cataracts within 10 years, often requiring surgical intervention.
  • Long-term corticosteroid therapy significantly accelerates cataract formation post-transplant.
  • Consideration of preventive strategies, such as ocular shielding during TBI, is recommended to mitigate cataract risk.